BPC-157 TB-500 (20 mg) | Laboratory Research Blend

TECHNICAL SPECIFICATIONS

• Total content: 20 mg, comprising 10 mg BPC-157 and 10 mg TB-500.
• Appearance: White lyophilized solid, supplied as a compressed cake or pellet.
• Grade: Laboratory reagent, >99% purity.
• Solvent context: Aqueous solvent systems for laboratory assays. Assess solubility and stability under the selected assay conditions.
• Storage: −20 °C for long-term material storage.

For laboratory research use only. Not for use in humans or animals.

RESEARCH FORMAT AND ASSAY CONTEXT

The 20 mg format supplies a predefined 1:1 mass ratio of BPC-157 and TB-500 in one co-lyophilized laboratory reagent. Its composition supports research designs that examine the two components within a defined material system.

BPC-157 is investigated in nitric oxide and angiogenic signaling research, including VEGF-associated pathways. The TB-500 fragment is studied in actin-interaction, cytoskeletal organization, cell migration, and motility assays. A combined format introduces multiple experimental variables; a synergistic interaction must be evaluated rather than assumed.

Chemical Structures (BPC-157  TB-500)

Chemical Structure of BPC 157 (Pentadecapeptide)

2D chemical structure diagram of BPC-157 (pentadecapeptide), CAS 137525-51-0 -research-grade peptide intended for angiogenesis pathway studies.

Molecular structure of BPC-157: a synthetic pentadecapeptide (15 amino acids) based on a sequence identified in gastric material (sequence begins Gly-Glu-Pro-Pro-Pro…). Source: PubChem CID 9941957.

Chemical Structure of TB500 Fragment (Ac-LKKTETQ)

2D chemical structure of the TB-500 fragment (Ac-LKKTETQ), CAS 885340-08-9 – a fragment associated with actin-binding/actin dynamics research (thymosin beta-4-derived).

Molecular structure of TB-500 (a PubChem-listed thymosin beta-4 fragment). Its active 7-amino acid sequence (Ac-LKKTETQ) is commonly cited as the motif associated with cell migration in mechanistic discussions. Source: PubChem CID 16132341.

COMPONENT RESEARCH CONTEXT

MATERIAL SOURCING AND STORAGE

Co-lyophilization provides the two components in a predefined ratio, reducing variability associated with separate component measurements during laboratory preparation.

Inventory is maintained at −20 °C and dispatched with active cold packs. Temperature exposure during shipping and laboratory handling is relevant to peptide integrity. Follow the material documentation for storage and handling requirements.

LABORATORY SAFETY

Use nitrile gloves and appropriate laboratory PPE. Refer to the Safety Data Sheet (SDS) for BPC-157, CAS 137525-51-0, and the TB-500 fragment, CAS 885340-08-9. Follow institutional chemical-safety and disposal procedures.

Frequently Asked Questions

What laboratory context is described for this blend?

The blend contains 10 mg BPC-157 and 10 mg TB-500. BPC-157 is discussed in nitric oxide and VEGF-associated signaling research, while the TB-500 fragment is discussed in actin dynamics, cytoskeletal organization, and cell migration assays. These are distinct assay contexts; the blend format does not establish a synergistic effect.

Which TB-500 structure is referenced on this page?

The referenced structure is the thymosin beta-4-derived fragment Ac-LKKTETQ, CAS 885340-08-9, PubChem CID 16132341. Full-length thymosin beta-4 contains 43 amino acids; the fragment contains seven amino acids and is discussed in actin-interaction research.

What laboratory safety and handling precautions apply?

Use nitrile gloves, eye protection, and a laboratory coat. Minimize aerosol generation and avoid inhalation or skin and eye contact when handling the lyophilized material or laboratory solutions. Refer to the SDS for CAS 137525-51-0 and 885340-08-9, and follow institutional chemical-safety and disposal procedures.

What solvent-system considerations apply to laboratory assays?

Aqueous solvent systems are discussed for BPC-157 and the TB-500 fragment in laboratory research. BPC-157 has been reported as stable under acidic conditions, and the TB-500 fragment is described as water-soluble. Select the solvent system according to assay requirements and material documentation. Solubility and stability should be evaluated for the specific assay conditions.

For laboratory research use only. Not for use in humans or animals.